Cormorant Asset Management’s Autolus Therapeutics AUTL Stock Holding History

Cormorant Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,616,667	Closed	-$42.2M	–	53
2024 Q1	$42.2M	Buy	6,616,667 +1,166,667	+21%	+$7.28M	1.85%	15
2023 Q4	$35.1M	Buy	5,450,000 +5,057,833	+1,290%	+$19.3M	1.68%	18
2023 Q3	$914K	Hold	392,167	–	–	0.05%	47
2023 Q2	$933K	Hold	392,167	–	–	0.05%	60
2023 Q1	$722K	Hold	392,167	–	–	0.05%	65
2022 Q4	$745K	Hold	392,167	–	–	0.05%	68
2022 Q3	$839K	Hold	392,167	–	–	0.06%	65
2022 Q2	$1.11M	Hold	392,167	–	–	0.08%	69
2022 Q1	$1.64M	Hold	392,167	–	–	0.13%	70
2021 Q4	$2.04M	Hold	392,167	–	–	0.12%	70
2021 Q3	$2.57M	Hold	392,167	–	–	0.1%	80
2021 Q2	$2.6M	Sell	392,167 -30,000	-7%	-$186K	0.09%	90
2021 Q1	$2.42M	Hold	422,167	–	–	0.05%	106
2020 Q4	$3.77M	Hold	422,167	–	–	0.09%	90
2020 Q3	$4.91M	Sell	422,167 -57,821	-12%	-$838K	0.19%	76
2020 Q2	$7.69M	Hold	479,988	–	–	0.29%	62
2020 Q1	$2.88M	Hold	479,988	–	–	0.13%	65
2019 Q4	$6.34M	Hold	479,988	–	–	0.25%	56
2019 Q3	$5.96M	Sell	479,988 -220,012	-31%	-$2.91M	0.36%	53
2019 Q2	$11.3M	Sell	700,000 -150,000	-18%	-$3.35M	0.65%	46
2019 Q1	$26.8M	Buy	+850,000	New	+$24.2M	1.81%	22
2018 Q4	–	Sell	-1,326,136	Closed	-$40.7M	–	71
2018 Q3	$40.7M	Sell	1,326,136 -199,451	-13%	-$5.38M	2.64%	13
2018 Q2	$40.9M	Buy	+1,525,587	New	+$40.3M	3.02%	9

Other funds holding AUTL

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cormorant Asset Management's AUTL Position: Q2 2024 in Review

Cormorant Asset Management sold out of Autolus Therapeutics (AUTL) in Q2 2024, closing a stake of 6,616,667 shares — an estimated $42.2M sold.

Cormorant Asset Management first reported a position in AUTL in Q2 2018 and held it in 23 quarters. The position peaked at $42.2M in Q1 2024. 111 funds tracked by Wall St. Rank hold AUTL as of Q2 2024.

Cormorant Asset Management reported no remaining Autolus Therapeutics position as of Q2 2024 after selling out during the quarter.
Cormorant Asset Management sold 6,616,667 Autolus Therapeutics shares in Q2 2024, an estimated $42.2M.
Cormorant Asset Management first reported a position in Autolus Therapeutics in Q2 2018 and held it in 23 quarters.
Cormorant Asset Management's Autolus Therapeutics position peaked at $42.2M in Q1 2024.
111 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2024.

Based on Cormorant Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.